Right now, Costa says, the company does not know what the data from its clinical trials will show, but Novartis is very optimistic about Prexige based on earlier data.

FORBES: Novartis Looks To Prexige, A New Arthritis Drug

"When they first released their data, they had to massage some data to show a clinical difference, " he says.

FORBES: Magazine Article

He uses these data to show how Big Pharma hides negative clinical trial results.

FORBES: PhRMA Is Not Effective in Improving the Image of the Pharma Industry